 |
 |
Danone in talks to buy Wockhardt's nutrition business: report
26 July 2011
|
|
 |
 |
Wockhardt receives tentative US FDA approval for generic version of Patanol ophthalmic solution
01 July 2011
|
 |
 |
Wockhardt launches three new products in the United States
21 June 2011
|
| | |
 |
 |
Wockhardt receives US FDA approval for generic Alzheimer's drug
25 April 2011
|
 |
 |
Wockhardt's generic version of Pfizer's Effexor XR capsules gets US FDA approval
19 April 2011
|
 |
 |
HC stays winding-up plea against Wockhardt
23 March 2011
|
 |
 |
HC nod for winding up Wockhardt; company to appeal
12 March 2011
|
 |
 |
Wockhardt launches generic version of ulcer drug `Protonix' in US
21 January 2011
|
 |
 |
Wockhardt launches prostate drug Flomax in the US
28 April 2010
|
 |
 |
Wockhardt deal with Abbott falls through as foreign investors cry foul
03 April 2010
|
 |
 |
Bombay HC rejects plea to block Wockhardt deal with Abbott
18 January 2010
|
 |
 |
Wockhardt receives US FDA approval for antibacterial Levofloxacin
13 January 2010
|
 |
 |
Wockhardt gets US FDA approval for Alzheimer's drug Memantine
06 January 2010
|
 |
 |
Fortis completes deal to pocket 10 Wockhardt hospitals
19 December 2009
|
 |
 |
Wockhardt settles with lender DBS Bank out of court
30 November 2009
|
 |
 |
Wockhardt launches anti-hypertension drug Nicardipine injections in the US
18 November 2009
|
 |
 |
Wockhardt reports Rs54 crore Q3 net loss
31 October 2009
|
 |
 |
Wockhardt receives US FDA approval for prostrate drug
29 September 2009
|
 |
 |
Wockhardt is top Indian pharma patentee; bags government award
24 September 2009
|
 |
 |
Fortis acquires 10 Wockhardt hospitals for Rs909 crore
24 August 2009
|
 |
 |
Wockhard to sell 10 hospitals to Fortis for around Rs1,200 crore
22 August 2009
|
 |
 |
Wockhardt completes sale of veterinary business to Vétoquinol
20 August 2009
|
 |
 |
Wockhardt sells its nutrition businesses to Abbott for $130 million
28 July 2009
|
 |
 |
Cash-strapped Wockhardt sells veterinary arm to France’s Vetoquinol
29 June 2009
|
 |
 |
Wockhardt sells German arm to Mova Pharma
18 June 2009
|
 |
 |
Apollo Hospitals dumps plan to acquire Wockhardt assets
17 June 2009
|
 |
 |
Wockhardt to hive off animal health care business
07 May 2009
|
 |
 |
Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt
06 May 2009
|
 |
 |
Wockhardt settles patent row with Orion Corporation
29 April 2009
|
 |
 |
Wockhardt reports Rs139 crore net loss in Q4'08
25 April 2009
|
 |
 |
Wockhardt CMD Khorakiwala quits; Fortis takeover likely
01 April 2009
|
 |
 |
Wockhardt’s debt hard pill to swallow for investors
01 April 2009
|
 |
 |
Fortis seeks nod for rights issue; may acquire Wockhartdt
31 March 2009
|
 |
 |
Wockhardt to launch ulcer drug Ranitidine in the US
26 February 2009
|
 |
 |
Wockhardt gets US FDA approval for paediatrics drug
04 December 2008
|
 |
 |
Wockhardt gets USFDA approval for insomnia drug sale
14 November 2008
|
 |
 |
Wockhardt gets US FDA nod to market Ceftazidime injections
16 October 2008
|
 |
 |
Lintas Bangalore bags Wockhardt account
13 October 2008
|
 |
 |
Wockhardt says derivative losses not to affect Q1 performance
24 March 2008
|
 |
 |
Wockhardt's Azithromycin to battle Pfizer's Zithromax in the US market
13 February 2008
|
 |
 |
Emaar IPO yet undersubscribed; Wockhardt withdraws issue
07 February 2008
|
 |
 |
Wockhardt Hospitals plans Rs569 crore investment in hospital projects
21 January 2008
|
 |
 |
Wockhardt to demerge R&D business
18 January 2008
|
 |
 |
Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US
02 January 2008
|
 |
 |
Wockhardt
acquires US pharma firm Morton Grove Pharmaceuticals
24 October 2007
|
 |
 |
Wockhardt
gets US FDA nod to enter the $2.6 billion Norvasc market
17 September 2007
|
 |
 |
Wockhardt acquires France`s Negma Labs for Rs1,090 crore
03 May 2007
|
 |
 |
Internal accruals to fund Negma acquisition: Khorakiwala
03 May 2007
|
 |
 |
Wockhardt to launch Italy''s B-Lift range of dermatology
products in India
23 April 2007
|
 |
 |
Wockhardt to introduce treatment for dermatological
scars
17 April 2007
|
 |
 |
The bigger picture
04 April 2007
|
 |
 |
What the benefactors say
04 April 2007
|
 |
 |
Wockhardt receives US FDA approval for diuretic injection
28 March 2007
|
 |
 |
Healthcare industry demands deeper reforms
28 February 2007
|
 |
 |
Wockhardt signs in-licensing pact with Crawford Healthcare of UK
22 January 2007
|
 |
 |
Wockhardt, Dr Reddy's launch generic Ondansetron in the US
27 December 2006
|
 |
 |
FDA orders withdrawal of Wockhardt's insulin brand 'Wosulin'
25 November 2006
|
 |
 |
Wockhardt Q3 net up 14 per cent at Rs74 crore, sales up 22 per cent at Rs438 crore
26 October 2006
|
 |
 |
Wockhardt acquires Pinewood for $150 million, fourth European acquisition
03 October 2006
|
 |
 |
Wockhardt to upgrade and manage hospital in Rajkot
20 September 2006
|
 |
 |
Wockhardt to develop SEZ near Aurangabad for its global biopharma hub
18 September 2006
|
 |
 |
Wockhardt close to acquiring Pinewood: CNBC
13 September 2006
|
 |
 |
Wockhardt's Cefotaxime injection receives US FDA approval
31 August 2006
|
 |
 |
Wockhardt acquires Dumex with Protinex, Farex brands from Royal Numico NV
30 June 2006
|
 |
 |
Wockhardt UK expanding Byetta manufacturing capacity
16 June 2006
|
 |
 |
Wockhardt gets US FDA approval for anti-epilepsy drug
14 June 2006
|
 |
 |
Wockhardt in-licenses dermatology drug from LSI of UK
05 June 2006
|
 |
 |
Wockhardt receives US FDA approval for clarithromycin tablets
01 June 2006
|
 |
 |
US FDA approves Wockhardt's Waluj plant
11 May 2006
|
 |
 |
Huzaifa
Khorakiwala Dr Murtaza Khorakiwala join Wockhardt board
16 March 2006
|
 |
 |
Wockhardt to raise up to $800 million to fund overseas acquisitions
16 March 2006
|
 |
 |
Wockhardt receives US FDA approval for Ranitidine OTC version
27 February 2006
|
 |
 |
Wockhardt
amongst first to receive US FDA approval for Zonisamide
Capsules
26 December 2005
|
 |
 |
Wockhardt
becomes South Asia''s first JCI-accredited super-speciality
hospital
11 November 2005
|
 |
 |
Datamatics appoints H Khorakiwala, Dr Uday Salunkhe as
independent directors
27 October 2005
|
 |
 |
Wockhardt
becomes only pharmaceutical Superbrand in India
20 July 2005
|
 |
 |
Wockhardt
joins $billion league
20 July 2005
|
 |
 |
Wockhardt launches
India''s first automatic insulin delivery device and recombinant insulin
cartridge
17 February 2005
|
 |
 |
Wockhardt
acquires German firm Esparma
07 May 2004
|
 |
 |
Wockhardt
Hospital wins excellence in communications awards
26 March 2004
|
 |
 |
Human
touch for humanity
05 September 2003
|
 |
 |
Wockhardt
buys CP Pharma
10 July 2003
|
 |
 |
There
is no plan to sell Vitamin B12 business, says Wockhardt
24 June 2003
|
 |
 |
Harvard
Medical International, Wockhardt honour five doctors
17 February 2003
|
 |
 |
Wockhardt
in talks with Watson
24 December 2001
|
 |
 |
Pharma
companies in talks with MIDC
13 December 2001
|
 |
 |
Leading
firms, Specialty Ranbaxy tie up
01 December 2001
|
 |
 |
Wockhardt files investigational application
15 November 2001
|
 |
 |
Drug
prices revised, Wockhardt to gain
13 August 1999
|
 |
 |
Wockhardt preparing for
competition
27 April 1999
|
 |
 |
Wockhardt to separate non-pharma
business
23 April 1999
|
 |
 |
Wockhardt sets Rs 70-crore
target for nutrition business
22 April 1999
|
 |
 |
The
story so far
01 January 1900
|
 |
 |
What
Wockhardt did
01 January 1900
|